➡️ The FDA is warning people to avoid using compounded medicines as substitutes for the popular weight loss and diabetes drugs Ozempic, Rybelsus, and Wegovy.
The FDA is warning people to avoid using compounded medicines as substitutes for the popular weight loss and diabetes drugs Ozempic, Rybelsus, and Wegovy.
Agency officials are concerned that the compounded versions may contain ingredients that sound like the brand name drugs' active ingredient, semaglutide, but are different because the ingredients are in salt form.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns about compounded versions of popular weight loss drugsFederal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
Read more »
Ozempic Craze Has Spawned a Sketchy Black Market, FDA WarnsThe FDA has received adverse event reports from people using compounded semaglutide, which might not contain the same version of the popular obesity drug.
Read more »
FDA warns consumers not to use off-brand versions of Ozempic, WegovyConsumers should only use semaglutide prescribed by a health care provider and filled by a licensed pharmacy, FDA said.
Read more »
FDA warns consumers not to use off-brand versions of Ozempic, WegovySales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss.
Read more »
FDA warns consumers not to use off-brand versions of Ozempic, WegovyThe U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.
Read more »